Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Influenza

Towards a single flu vaccine

Vaccines against the pandemic H1N1 influenza strain of 2009 also generated immunity to other diverse flu viruses.

A team including Rafi Ahmed at Emory University in Atlanta, Georgia, and Patrick Wilson at the University of Chicago in Illinois previously showed that people infected with pandemic H1N1 flu made antibodies that neutralized both H1N1 and other flu strains. Now the researchers have analysed immune cells from 24 people who received an H1N1 vaccine, and found that these cells also produce these broadly neutralizing antibodies. The antibodies recognize conserved molecular features of both seasonal and pandemic flu strains — including the strain responsible for the 1918 pandemic.

The findings could aid the design of flu vaccines that recognize all flu viruses.

Proc. Natl Acad. Sci. USA http://dx.doi.org/10.1073/pnas.1118979109 (2012)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Towards a single flu vaccine. Nature 485, 551 (2012). https://doi.org/10.1038/485551a

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing